Bankrupt Insys offers to turn out its almost empty pockets for plaintiffs
Facing $4B in claims, Insys doubts ability to pay out via Chapter 11
Bankrupt Insys cleared to sell opioid spray Subsys in $20M deal
Study links opioid epidemic to painkiller marketing
DEA Issues Safety Alert About Potent Opioid